Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.
Biomark Res. 2020 Oct 24;8:54. doi: 10.1186/s40364-020-00234-z. eCollection 2020.
Biomark Res. 2020.
PMID: 33110606
Free PMC article.
Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL.
Cuesta-Mateos C, Juárez-Sánchez R, Mateu-Albero T, Loscertales J, Mol W, Terrón F, Muñoz-Calleja C.
Cuesta-Mateos C, et al. Among authors: juarez sanchez r.
MAbs. 2021 Jan-Dec;13(1):1917484. doi: 10.1080/19420862.2021.1917484.
MAbs. 2021.
PMID: 33944659
Free PMC article.
Item in Clipboard
Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody.
Mateu-Albero T, Juárez-Sánchez R, Loscertales J, Mol W, Terrón F, Muñoz-Calleja C, Cuesta-Mateos C.
Mateu-Albero T, et al. Among authors: juarez sanchez r.
Cancer Immunol Immunother. 2022 Mar;71(3):627-636. doi: 10.1007/s00262-021-03014-2. Epub 2021 Jul 23.
Cancer Immunol Immunother. 2022.
PMID: 34297159
Free PMC article.
Item in Clipboard
Evaluation of therapeutic targeting of CCR7 in acute graft-versus-host disease.
Cuesta-Mateos C, Portero-Sainz I, García-Peydró M, Alcain J, Fuentes P, Juárez-Sánchez R, Pérez-García Y, Mateu-Albero T, Díaz-Fernández P, Vega-Piris L, Sánchez-López BA, Marcos-Jiménez A, Cardeñoso L, Gómez-García de Soria V, Toribio ML, Muñoz-Calleja C.
Cuesta-Mateos C, et al. Among authors: juarez sanchez r.
Bone Marrow Transplant. 2020 Oct;55(10):1935-1945. doi: 10.1038/s41409-020-0830-8. Epub 2020 Feb 21.
Bone Marrow Transplant. 2020.
PMID: 32086495
Item in Clipboard
Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses.
Serra López-Matencio JM, Pérez García Y, Meca-Lallana V, Juárez-Sánchez R, Ursa A, Vega-Piris L, Pascual-Salcedo D, de Vries A, Rispens T, Muñoz-Calleja C.
Serra López-Matencio JM, et al. Among authors: juarez sanchez r.
Front Neurol. 2021 Oct 7;12:716548. doi: 10.3389/fneur.2021.716548. eCollection 2021.
Front Neurol. 2021.
PMID: 34690914
Free PMC article.
Item in Clipboard
Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment.
Relaño-Rodríguez I, Juárez-Sánchez R, Pavicic C, Muñoz E, Muñoz-Fernández MÁ.
Relaño-Rodríguez I, et al. Among authors: juarez sanchez r.
J Nanobiotechnology. 2019 May 21;17(1):69. doi: 10.1186/s12951-019-0500-4.
J Nanobiotechnology. 2019.
PMID: 31113488
Free PMC article.
Item in Clipboard
Cite
Cite